Nuvectis Pharma reported net income of -$7.02M for the quarter ended Jun 2026. This income statement covers 21 quarters of results from Jun 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 4.51M | 4.51M | 9.16M | 12.72M | 14.64M | 12.66M | 16.01M | 17.22M | 17.31M | 17.42M | 18.36M | 18.75M | 18.99M | 19.50M | 23.63M | 23.88M | 25.64M | 25.68M | 26.53M | 26.69M | |
| Operating items | |||||||||||||||||||||
| Research & DevelopmentR&D | 4.16M | 1.14M | 1.80M | 2.50M | 4.52M | 4.40M | 2.37M | 4.26M | 4.49M | 4.26M | 2.66M | 2.94M | 2.82M | 4.50M | 3.68M | 3.61M | 5.77M | 5.09M | 4.11M | 4.68M | |
| Selling, General & AdministrativeSG&A | 0.51M | 1.12M | 1.14M | 1.07M | 1.42M | 2.38M | 1.73M | 1.51M | 1.67M | 2.60M | 1.74M | 1.70M | 1.54M | 1.95M | 1.89M | 2.98M | 2.02M | 2.53M | 2.15M | 2.51M | |
| Operating ExpensesOpex | 4.67M | 2.27M | 2.94M | 3.57M | 5.94M | 6.78M | 4.10M | 5.77M | 6.16M | 6.87M | 4.40M | 4.64M | 4.36M | 6.45M | 5.57M | 6.59M | 7.79M | 7.62M | 6.26M | 7.20M | |
| Operating IncomeOp. Inc | -4.67M | -2.27M | -2.94M | -3.57M | -5.94M | -6.78M | -4.10M | -5.77M | -6.16M | -6.87M | -4.40M | -4.64M | -4.36M | -6.45M | -5.57M | -6.59M | -7.79M | -7.62M | -6.26M | -7.20M | |
| EBIT | -4.67M | -2.27M | -2.94M | -3.57M | -5.94M | -6.78M | -4.10M | -5.77M | -6.16M | -6.87M | -4.40M | -4.64M | -4.36M | -6.45M | -5.57M | -6.59M | -7.79M | -7.62M | -6.26M | -7.20M | |
| Non-operating items | |||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00M | 0.00M | 0.06M | 0.08M | 0.05M | 0.06M | 0.28M | 0.24M | 0.23M | 0.21M | 0.21M | 0.20M | 0.24M | 0.26M | 0.33M | 0.30M | 0.21M | 0.18M | |||
| Net income details | |||||||||||||||||||||
| EBT | -4.67M | -2.27M | -2.94M | -3.57M | -5.88M | -6.70M | -4.05M | -5.71M | -5.88M | -6.62M | -4.17M | -4.43M | -4.15M | -6.25M | -5.33M | -6.33M | -7.46M | -7.31M | -6.05M | -7.02M | |
| Profit After TaxPAT | -4.67M | -2.26M | -2.94M | -3.57M | -5.88M | -6.70M | -4.05M | -5.71M | -5.88M | -6.62M | -4.17M | -4.43M | -4.15M | -6.25M | -5.33M | -6.33M | -7.46M | -7.31M | -6.05M | -7.02M | |
| Income from Continuing OperationsIncome (Continuing) | -4.67M | -2.27M | -2.94M | -3.57M | -5.88M | -6.70M | -4.05M | -5.71M | -5.88M | -6.62M | -4.17M | -4.43M | -4.15M | -6.25M | -5.33M | -6.33M | -7.46M | -7.31M | -6.05M | -7.02M | |
| Consolidated Net IncomeConsol Net Inc. | -4.67M | -2.27M | -2.94M | -3.57M | -5.88M | -6.70M | -4.05M | -5.71M | -5.88M | -6.62M | -4.17M | -4.43M | -4.15M | -6.25M | -5.33M | -6.33M | -7.46M | -7.31M | -6.05M | -7.02M | |
| Income towards Parent CompanyParent Net Inc | -4.67M | -2.27M | -2.94M | -3.57M | -5.88M | -6.70M | -4.05M | -5.71M | -5.88M | -6.62M | -4.17M | -4.43M | -4.15M | -6.25M | -5.33M | -6.33M | -7.46M | -7.31M | -6.05M | -7.02M | |
| Net Income towards Common StockholdersNet Income | -4.67M | -2.26M | -2.94M | -3.57M | -5.88M | -6.70M | -4.05M | -5.71M | -5.88M | -6.62M | -4.17M | -4.43M | -4.15M | -6.25M | -5.33M | -6.33M | -9.89M | -7.31M | -6.05M | -7.02M | |
| Additional items | |||||||||||||||||||||
| EPS (Basic) | -1.04 | -0.53 | -0.32 | -0.28 | -0.42 | -0.53 | -0.27 | -0.38 | -0.37 | -0.43 | -0.25 | -0.26 | -0.24 | -0.37 | -0.27 | -0.30 | -0.44 | -0.34 | -0.26 | -0.30 | |
| EPS (Diluted) | -1.04 | -0.53 | -0.32 | -0.28 | -0.42 | -0.53 | -0.27 | -0.38 | -0.37 | -0.43 | -0.25 | -0.26 | -0.24 | -0.37 | -0.27 | -0.30 | -0.44 | -0.34 | -0.26 | -0.30 | |
| Shares Outstanding | 4.51M | 4.27M | 9.16M | 12.72M | 14.05M | 12.66M | 14.72M | 15.18M | 16.10M | 15.56M | 16.56M | 16.90M | 17.23M | 17.11M | 19.94M | 21.37M | 22.72M | 21.81M | 23.41M | 23.48M | |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 4.51M | 4.27M | 9.16M | 12.72M | 14.05M | 12.66M | 14.72M | 15.18M | 16.10M | 15.56M | 16.56M | 16.90M | 17.23M | 17.11M | 19.94M | 21.37M | 22.72M | 21.81M | 23.41M | 23.48M | |
| EBITDA | -4.67M | -2.27M | -2.94M | -3.57M | -5.94M | -6.78M | -4.10M | -5.77M | -6.16M | -6.87M | -4.40M | -4.64M | -4.36M | -6.45M | -5.57M | -6.59M | -7.79M | -7.62M | -6.26M | -7.20M |